Hippocampus

• Nightmares and the Cannabinoids (26 Sep 2024)
  
• Cannabinoids and monoaminergic system: implications for learning and memory (03 Sep 2024)
  
• Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy (29 Aug 2024)
  
• Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits (25 Aug 2024)
  
• Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry (20 Aug 2024)
  
• Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement (20 Aug 2024)
  
• Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities (20 Aug 2024)
  
• Neural Substrates of Incidental Associations and Mediated Learning: The Role of Cannabinoid Receptors (20 Aug 2024)
  
• Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders (20 Aug 2024)
  
• Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease (20 Aug 2024)
  
• Sex-dependent effects of in utero cannabinoid exposure on cortical function (19 Aug 2024)
  
• Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology (19 Aug 2024)
  
• Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system (18 Aug 2024)
  
• Cannabinoid Modulation of the Stressed Hippocampus (18 Aug 2024)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities (01 Sep 2022)
  
• Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
  
• Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures (05 Aug 2022)